ARTICLE | Company News
Bayer sales and marketing update
May 19, 2008 7:00 AM UTC
Bayer notified FDA of plans to withdraw all remaining supplies of Trasylol aprotinin from hospital pharmacies and warehouses following publication of data from the Canadian BART trial in The New Engl...